The brief

Analyst view

• Phantom Neuro's technology originated at Johns Hopkins University School of Medicine.
• The company raised $19M in Series A funding in early 2025, led by Ottobock, a major prosthetics manufacturer.
• CYBORG study approved April 2026 to evaluate Phantom X in up to 10 Australian amputees.

Technical approach

As reported

Muscle Interface

Implanted EMG sensor array

Small sensor array placed beneath the skin in the residual limb detects electromyographic (EMG) signals from remaining muscles.

Non-invasive nerve access

Avoids direct nervous system contact

System records from muscles rather than nerves or brain, eliminating the surgical complexity and risk of neural implants.

Signal translation

Real-time prosthetic control

Implanted telemetry module wirelessly transmits muscle signals to external controller that interprets intent and commands the prosthetic limb.